1. Home
  2. IVT vs LQDA Comparison

IVT vs LQDA Comparison

Compare IVT & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InvenTrust Properties Corp.

IVT

InvenTrust Properties Corp.

HOLD

Current Price

$28.04

Market Cap

2.1B

Sector

Real Estate

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$33.95

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IVT
LQDA
Founded
2005
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.5B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
IVT
LQDA
Price
$28.04
$33.95
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$32.00
$37.40
AVG Volume (30 Days)
527.9K
2.0M
Earning Date
10-28-2025
11-03-2025
Dividend Yield
3.40%
N/A
EPS Growth
1421.59
N/A
EPS
1.51
N/A
Revenue
$293,020,000.00
$69,216,000.00
Revenue This Year
$9.58
$904.79
Revenue Next Year
$6.83
$188.25
P/E Ratio
$18.54
N/A
Revenue Growth
9.60
343.41
52 Week Low
$25.21
$10.37
52 Week High
$31.51
$34.02

Technical Indicators

Market Signals
Indicator
IVT
LQDA
Relative Strength Index (RSI) 48.34 69.52
Support Level $28.22 $30.50
Resistance Level $28.88 $32.80
Average True Range (ATR) 0.50 1.82
MACD 0.04 0.31
Stochastic Oscillator 40.97 99.22

Price Performance

Historical Comparison
IVT
LQDA

About IVT InvenTrust Properties Corp.

InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: